1. Putra, J, Al-Ibraheemi, A. Adipocytic tumors in children: a contemporary review. Semin Diagn Pathol. 2019; 36(2):95–104.
Google Scholar | Crossref | Medline2. Özşen, M, Yalçinkaya, U, Yazici, Z, Sarisözen, MB. Lipomatous tumors in pediatric patients: a retrospective analysis of 50 cases. Turk Patoloji Derg. 2020; 36(1):1–10.
Google Scholar | Medline3. Coffin, CM. Lipoblastoma: an embryonal tumor of soft tissue related to organogenesis. Semin Diagn Pathol. 1994; 11:98–103.
Google Scholar | Medline | ISI4. McVay, MR, Keller, JE, Wagner, CW, Jackson, RJ, Smith, SD. Surgical management of lipoblastoma. J Pediatr Surg. 2006; 41:1067–1071.
Google Scholar | Crossref | Medline5. Dilley, AV, Patel, DL, Hicks, MJ, et al. Lipoblastoma: pathophysiology and surgical management. J Pediatr Surg. 2001; 36:229–231.
Google Scholar | Crossref | Medline | ISI6. Kok, KY, Telisinghe, PU. Lipoblastoma: clinical features, treatment, and outcome. World J Surg. 2010; 34:1517–1522.
Google Scholar | Crossref | Medline | ISI7. Zatkova, A, Rouillard, JM, Hartmann, W, et al. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer. 2004; 39(2):126–137.
Google Scholar | Crossref | Medline | ISI8. Voz, ML, Agten, NS, Van de Ven, WJ, Kas, K. PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res. 2000; 60(1):106–113.
Google Scholar | Medline9. Hensen, K, Van Valckenborgh, IC, Kas, K, Van de Ven, WJ, Voz, ML. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res. 2002; 62:1510–1517.
Google Scholar | Medline | ISI10. Declercq, J, Van Dyck, F, Braem, CV, et al. Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression. Cancer Res. 2005; 65(11):4544–53.
Google Scholar | Crossref | Medline | ISI11. Hibbard, MK, Kozakewich, HP, Dal Cin, P, et al. PLAG1 fusion oncogenes in lipoblastoma. Cancer Res. 2000; 60:4869–4872.
Google Scholar | Medline | ISI12. Gisselsson, D, Hibbard, MK, Dal Cin, P, et al. PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms. Am J Pathol. 2001; 159:955–962.
Google Scholar | Crossref | Medline13. Yoshida, H, Miyachi, M, Ouchi, K, et al. Identification of COL3A1 and RAB2A as novel translocation partner genes of PLAG1 in lipoblastoma. Genes Chromosomes Cancer. 2014; 53:606–611.
Google Scholar | Crossref | Medline14. Deen, M, Ebrahim, S, Schloff, D, et al. A novel PLAG1-RAD51L1 gene fusion resulting from a t(8;14)(q12;q24) in a case of lipoblastoma. Cancer Genet. 2013; 206:233–237.
Google Scholar | Crossref | Medline15. Nitta, Y, Miyachi, M, Tomida, A, et al. Identification of a novel BOC-PLAG1 fusion gene in a case of lipoblastoma. Biochem Biophys Res Commun. 2019; 512(1):49–52.
Google Scholar | Crossref | Medline16. Krsková, L, Němečková, T, Balko, J, Brož, P, Vícha, A. Novel ZEB2-PLAG1 fusion gene identified by RNA sequencing in a case of lipoblastoma. Pediatr Blood Cancer. 2021: 68(3):e28691.
Google Scholar | Crossref | Medline17. Morerio, C, Nozza, P, Tassano, E, et al. Differential diagnosis of lipoma-like lipoblastoma. Pediatr Blood Cancer. 2009; 52:132–134.
Google Scholar | Crossref | Medline | ISI18. Lopez-Nunez, O, Alaggio, R, Ranganathan, S, et al. New molecular insights into the pathogenesis of lipoblastomas: clinicopathologic, immunohistochemical, and molecular analysis in pediatric cases. Hum Pathol. 2020; 104:30–41.
Google Scholar | Crossref | Medline19. Fritchie, K, Wang, L, Yin, Z, et al. Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners. Mod Pathol. 2021; 34(3):584–591.
Google Scholar | Crossref | Medline20. Pedeutour, F, Deville, A, Steyaert, H, et al. Rearrangement of HMGA2 in a case of infantile lipoblastoma without Plag1 alteration. Pediatr Blood Cancer. 2012; 58:798–800.
Google Scholar | Crossref | Medline21. Warren, M, Turpin, BK, Mark, M, Smolarek, TA, Li, X. Undifferentiated myxoid lipoblastoma with PLAG1-HAS2 fusion in an infant; morphologically mimicking primitive myxoid mesenchymal tumor of infancy (PMMTI)–diagnostic importance of cytogenetic and molecular testing and literature review. Cancer Genet. 2016; 209(1-2):21–29.
Google Scholar | Crossref | Medline22. Cooley, LD, Morton, CC, Sanger, WG, Saxe, DF, Mikhail, FM. Section E6.5-6.8 of the ACMG technical standards and guidelines: chromosome studies of lymph node and solid tumor-acquired chromosomal abnormalities. Genet Med. 2016; 18(6):643–648.
Google Scholar | Crossref | Medline23. Barch, MJ, Knutsen, T, Spurbeck, JL. The AGT Cytogenetics Laboratory Manual. Philadelphia: Lippincott-Raven Publishers; 1997: 173–197.
Google Scholar24. Hiemenz, MC, Ostrow, DG, Busse, TM, et al. OncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies. J Mol Diagn. 2018; 20:765–776.
Google Scholar | Crossref | Medline25. Foster, JM, Oumie, A, Togneri, FS, et al. Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling. BMC Med Genomics. 2015; 8:5.
Google Scholar | Crossref | Medline | ISI